$GBLX : GB Sciences Applying for Medical Marijuana Licenses in Illinois
2014-07-18 14:31 ET - News Release
LAS VEGAS, July 18, 2014 /PRNewswire/ -- GrowBLOX Sciences, Inc. (OTCQB: GBLX) a medical marijuana research and development company, is applying for licenses to grow and dispense in Illinois. The timing couldn't be better for GB Sciences because Illinois State "lawmakers have set final rules to allow medical marijuana in Illinois, opening the door for patients to apply for ID cards this fall and to start purchasing legal cannabis by next spring" as was reported in the Chicago Tribune on Wednesday, July 16. The state intends to approve a total of 21 licenses for cultivation and 60 for dispensaries by September 2014.
CEO Craig Ellins explains, "Our familiarity with state legal processes and experience in filing for medical marijuana licenses in the state of Nevada, where we were granted a special use permit for a dispensary and cultivation facility, puts us at an advantage compared to the other local competitors filing for the same licenses in Illinois."
The Company believes their GrowBLOX™ technology is a perfect fit for the Illinois Medical Marijuana Market due to GB Sciences ability to meet or exceed the strict quality standards being imposed by the Illinois state legislature. To this end, "the Illinois Department of Agriculture is converting one of its labs into a testing center, where marijuana can be checked for potency, mold and pesticides so consumers know what they are getting," said Bob Morgan, coordinator of the state program as was also reported in the Chicago Tribune on Wednesday, July 16.
Illinois' medical marijuana market checks in at a purported 10,000 patients and will generate anywhere from $25 million to $45 million in cannabis sales, according to The Marijuana Business Factbook. The news of GB Sciences entrance into the Illinois market comes just days after The Company announced their entrance into the Florida Medical Marijuana Market through its subsidiary GB Sciences Florida, Inc.
About GB Sciences, Inc.
GrowBLOX Sciences, Inc., is a research and development company that has proprietary indoor growing chambers specifically designed for medical cannabis cultivation. The GrowBLOX™ chamber allows for completely controlled growing conditions, ensuring the manufacture of a consistent, toxin-free, natural and medicinal-grade product. The Company believes that the advantages of a controlled environment over traditional outdoor or greenhouse growing, will empower the public, nutraceutical and pharmaceutical industries to embrace cannabis as an effective treatment for a myriad of serious medical conditions. http://www.gbsciences.com
2014-07-18 14:31 ET - News Release
LAS VEGAS, July 18, 2014 /PRNewswire/ -- GrowBLOX Sciences, Inc. (OTCQB: GBLX) a medical marijuana research and development company, is applying for licenses to grow and dispense in Illinois. The timing couldn't be better for GB Sciences because Illinois State "lawmakers have set final rules to allow medical marijuana in Illinois, opening the door for patients to apply for ID cards this fall and to start purchasing legal cannabis by next spring" as was reported in the Chicago Tribune on Wednesday, July 16. The state intends to approve a total of 21 licenses for cultivation and 60 for dispensaries by September 2014.
CEO Craig Ellins explains, "Our familiarity with state legal processes and experience in filing for medical marijuana licenses in the state of Nevada, where we were granted a special use permit for a dispensary and cultivation facility, puts us at an advantage compared to the other local competitors filing for the same licenses in Illinois."
The Company believes their GrowBLOX™ technology is a perfect fit for the Illinois Medical Marijuana Market due to GB Sciences ability to meet or exceed the strict quality standards being imposed by the Illinois state legislature. To this end, "the Illinois Department of Agriculture is converting one of its labs into a testing center, where marijuana can be checked for potency, mold and pesticides so consumers know what they are getting," said Bob Morgan, coordinator of the state program as was also reported in the Chicago Tribune on Wednesday, July 16.
Illinois' medical marijuana market checks in at a purported 10,000 patients and will generate anywhere from $25 million to $45 million in cannabis sales, according to The Marijuana Business Factbook. The news of GB Sciences entrance into the Illinois market comes just days after The Company announced their entrance into the Florida Medical Marijuana Market through its subsidiary GB Sciences Florida, Inc.
About GB Sciences, Inc.
GrowBLOX Sciences, Inc., is a research and development company that has proprietary indoor growing chambers specifically designed for medical cannabis cultivation. The GrowBLOX™ chamber allows for completely controlled growing conditions, ensuring the manufacture of a consistent, toxin-free, natural and medicinal-grade product. The Company believes that the advantages of a controlled environment over traditional outdoor or greenhouse growing, will empower the public, nutraceutical and pharmaceutical industries to embrace cannabis as an effective treatment for a myriad of serious medical conditions. http://www.gbsciences.com
GB Sciences, Inc. (GBLX) Stock Research Links
What I post is my opinion. Do your own DD. Make your own investment decision. Links, images, & retweets are not endorsements.
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
4️⃣Not Financial Advice. What I post is my opinion.
Also Paid for Advertising/IR/PR on Emerging Companies
Full Disclaimer: https://corporateads.com/disclaimer/
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
4️⃣Not Financial Advice. What I post is my opinion.
Also Paid for Advertising/IR/PR on Emerging Companies
Full Disclaimer: https://corporateads.com/disclaimer/
